Geertrui Vanhove

Geertrui Vanhove

Directeur Technique/Scientifique/R&D chez
Surrozen Operating, Inc.
61 ans
Health Technology
Consumer Services
Finance

Profil

Geertrui Vanhove is currently Chief Medical Officer at Surrozen Operating, Inc. since 2019 and Venture Partner at Longitude Capital Management Co LLC since 2023.
Former positions include Medical Director at Abbott Laboratories from 1996 to 1998, Medical Director at XOMA (US) LLC from 1998 to 2005, Vice President-Clinical Development at NeurogesX, Inc. from 2010 to 2011, Vice President-Medical Affairs at Assertio Therapeutics, Inc. from 2011 to 2012, VP, Head-Research & Development Search at Jazz Pharmaceuticals, Inc. from 2015 to 2019, Chief Medical Officer at Surrozen, Inc. from 2019 to 2021, and Independent Director at INSYS Therapeutics, Inc. from 2018 to 2020.
Education includes an MBA from St. Mary's College (Indiana) and a doctorate from Katholieke Universiteit Leuven.

Postes actifs de Geertrui Vanhove

SociétésPosteDébut
Directeur Technique/Scientifique/R&D 01/04/2019
Private Equity Investor 01/10/2023

Anciens postes connus de Geertrui Vanhove

SociétésPosteFin
SURROZEN, INC. Directeur Technique/Scientifique/R&D 31/03/2021
INSYS THERAPEUTICS, INC. Directeur/Membre du Conseil 01/02/2020
Directeur Technique/Scientifique/R&D 01/04/2019
Directeur Technique/Scientifique/R&D 01/05/2012
NEUROGESX, INC Corporate Officer/Principal 01/07/2011
Voir l'expérience en détail de Geertrui Vanhove

Formation de Geertrui Vanhove

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

66

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Geertrui Vanhove
🔇